Physician profile
Amber J Berry
NPI 1396004552
$9,063.43
in general payments reported to CMS, 2019-2025
26 companies · $3,148 in 2025
The $3,148 reported for 2025 was more than what 93% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $433 · 2021: $1,395 · 2022: $1,080 · 2023: $1,043 · 2024: $1,511 · 2025: $3,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,191 · Travel and Lodging: $1,355 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,191.11 |
| Travel and Lodging | $1,354.80 |
| Education | $155.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,770.40 | 2021-2025 | Inspire |
| Aerin Medical INC. | $1,118.77 | 2019-2025 | |
| Acclarent, INC | $1,064.88 | 2019-2024 | Acclarent Navwire, Relieva Spinplus, Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $725.95 | 2021-2025 | Dupixent |
| Stryker Corporation | $624.50 | 2019-2025 | Scopis Ent, 1788, Medline Industries, INC. |
| Medtronic, INC. | $560.42 | 2023-2025 | Nuvent, Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Genzyme Corporation | $551.39 | 2019-2025 | |
| Integra Lifesciences Corporation | $313.07 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Alk-Abello, INC | $232.12 | 2019-2024 | Odactra, Grastek, Ragwitek |
| Glaxosmithkline, LLC. | $191.40 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $172.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $156.90 | 2022-2024 | |
| Optinose US, INC. | $144.69 | 2019-2023 | |
| Hologic Sales and Service, LLC | $138.03 | 2022 | |
| Cochlear Americas | $41.66 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $40.36 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $39.62 | 2021-2023 | |
| Phathom Pharmaceuticals, INC. | $37.50 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $32.54 | 2023-2024 | Ryaltris |
| Smith+Nephew, INC. | $28.59 | 2021 | |
| Preceptis Medical, INC. | $15.02 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.52 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.02 | 2019 | |
| Pfizer INC. | $12.57 | 2019 | |
| Ethicon US, LLC | $11.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.